Crescent Biopharma (CBIO) AGM 2026 summary

Opening remarks and agenda

• Meeting opened with introductions of board members and executive team, including the independent auditor and secretary.

• Participants were reminded of voting procedures and meeting conduct rules.

• Notice of the meeting was confirmed as duly distributed to shareholders.

Board and executive committee updates

• Inspector of Election and secretary roles were formally introduced and their duties outlined.

• Quorum was confirmed for all proposals and director elections.

Shareholder proposals

• Proposal 1A: Election of Jonathan Violin as Class II Director for a three-year term.

• Proposal 1B: Election of Susan Moran as Class II Director for a three-year term.

• Proposal 2: Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026.

• Proposal 3: Advisory approval of executive officer compensation.

• Proposal 4: Advisory vote on frequency of future executive compensation votes.